This is the authors' abstract. We don't add key points for this paper.
β-Phenylalanine derivatives (β-PAD) represent a structural family of therapeutic interest, either as components of drugs or as starting materials for access to key compounds. As scaffolds for medicinal chemistry work, β-PAD offer the advantage of great diversity and modularity, a chiral pseudopeptidic character that opens up the capacity to be recognized by natural systems, and greater stability than natural α-amino acids. Nevertheless, their synthesis remains a challenge in drug discovery and numerous methods have been devoted to their preparation. This review is an update of the access routes to β-PAD and their various therapeutic applications.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Rémondin et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: